Results 241 to 250 of about 39,021 (326)

Breast Cancer: Molecular Pathogenesis, Targeted Therapy, Screening, and Prevention

MedComm, Volume 7, Issue 1, January 2026.
The review manuscript examines the molecular pathogenesis, screening, prevention advances, and evolving targeted therapies in breast cancer. It highlights the integration of AI and multiomics for precision prevention and personalized treatment, pointing toward future directions in equitable cancer care.
Huijun Lei, Jinzhen Fu, Wei Gu, Hongjin Qiao, Huixue Guo, Zijian Chen, San Ming Wang, Tianhui Chen   +7 more
wiley   +1 more source

Optimizing Liquid Biopsy: Spike-In Panel Approach for ctDNA Copy Number Variation Analysis. [PDF]

Cancer Genomics Proteomics
Kim H, Kim BM, Kim J, Seo SH, Hwang SM, Park KU.   +5 more
europepmc   +1 more source

Supplementary Figure S4 from ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial [PDF]

Ross A. Soo, Urania Dafni, Ji‐Youn Han, Byoung Chul Cho, Ernest Nadal, Chong Ming Yeo, Enric Carcereny, Javier de Castro, M.Á. Sala González, Linda Coate, Mariano Provencio, Christian Britschgi, Patrick Vagenknecht, Georgia Dimopoulou, Roswitha Kammler, Stephen P. Finn, Solange Peters, Rolf A. Stahel   +17 more
openalex   +1 more source

Nanotechnology‐Enhanced Approaches for Early Cancer Diagnosis

Nano Select, Volume 7, Issue 1, January 2026.
Conventional MRI and PET provide limited sensitivity and contrast for precise brain lesion detection. In contrast, radiolabeled nanoparticlebased PET imaging enables enhanced signal specificity and sensitivity. By integrating multifunctional nanoprobes, this platform improves multimodal imaging performance, allowing more accurate visualization of ...
Jongmoo Lee, Jiyu Kim, Eunhye Cho, Junyeop Jeong, Jayeon Song, Mikyung Kang   +5 more
wiley   +1 more source

PRIME: an interpretable artificial intelligence model based on liquid biopsy improves prediction of progression risk in non-small cell lung cancer. [PDF]

Mil Med Res
Wang Y, Xiang YB, Chen XW, Zhang T, Wang JY, Liu WY, Deng L, Wang LH, Gao SG, Bi N.   +9 more
europepmc   +1 more source

ctDNA MRD after CAR-T

Blood Advances
Salvatore Fiorenza, Mark R. Dowling
openaire   +1 more source

Plasma cell‐free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma

Clinical and Translational Medicine, Volume 16, Issue 1, January 2026.
Jacob E. Till, Ofer Gal‐Rosenberg, Sophia G. Giliberto, Nicholas J. Seewald, Dominique G. Ballinger, Heather E. Samberg, Melinda R. Yin, Qiao‐Li Wang, Samuele Cannas, Kristine N. Kim, Kyle Tien, Mohammed Sawi, Vidya Madineedi, C. Sloane Furniss, Vasilena Gocheva, Jonathan Nowak, Lauren K. Brais, Chen Yuan, Michael H. Rosenthal, Robert Roses, Ronald DeMatteo, Major Kenneth Lee, Charles Vollmer, Hersh Sagreiya, Mark H. O'Hara, Ruth Shemer, Brian Wolpin, Yuval Dor, Erica L. Carpenter   +28 more
wiley   +1 more source

Supplementary Table S6 from Round-Robin Comparison of RET Rearrangement Detection in ctDNA: A Novel Method for Limited Clinical Samples

Cloud P. Paweletz, Alison M. Urvalek, Minh Ha, Kavita Garg, Aimee Bence Lin, Anna M. Szpurka, Anthony Sireci, Geoffrey R. Oxnard, Pasi A. Jänne   +8 more
openalex   +1 more source

Lexicon for Clonal Hematopoiesis in Liquid Biopsy

Clinical and Translational Science, Volume 19, Issue 1, January 2026.
ABSTRACT Historically, clonal hematopoiesis (CH) has been recognized as a confounder of cell‐free DNA (cfDNA) testing. Recent evidence now demonstrates the role of CH as a risk factor in health, generating distinct sources of cfDNA that can be leveraged for liquid biopsy diagnostics.
Robert Tell, Ahmet Zehir, Andrew T. Anfora, Gargi Basu, Michelle Beidelschies, Carolyn Compton, Stephen Cristiano, James H. Godsey, John Hu, Donald J. Johann, Marisa Juntilla, Rina Kansal, Christine Lo, Dorys Lopez Ramos, Vaidhyanathan Mahaganapathy, David Merriam, Christian Rolfo, Hugh Russell, Usha Singh, Daniel Stetson, Martin You, Lauren C. Leiman   +21 more
wiley   +1 more source

Liquid Biopsy and Circulating Biomarkers in Head and Neck Cancer: Advancing Non-Invasive Detection and Tailored Management. [PDF]

Cancers (Basel)
Morelli I, Ghirardini C, Faccani L, Casanova C, Fernandez IJ, Tamberi S.   +5 more
europepmc   +1 more source